Trinity Biotech reported $4.71M in Selling and Administration Expenses for its fiscal quarter ending in March of 2026.





Selling And Administration Expenses Change Date
Abbott USD 4.27B 669M Sep/2026
Bayer EUR 4.02B 53M Sep/2026
Bio-Rad Laboratories USD 212M 400K Jun/2026
EDAP TMS EUR 12.92M 4.1M Mar/2026
J&J USD 6.25B 168M Sep/2026
Mesa Laboratories USD 27.31M 380K Sep/2024
OraSure Technologies USD 13.21M 3.29M Dec/2025
Plus Therapeutics USD 4.26M 779K Mar/2026
Roche Holding CHF 6.37B 908M Jun/2026
Siemens EUR 4.19B 434M Sep/2026
Thermo Fisher Scientific USD 1.86B 46M Sep/2026
Tosoh JPY 43.47B 29M Sep/2026
Trinity Biotech USD 4.71M 1.08M Mar/2026
Veracyte USD 57.95M 2.25M Sep/2026